Conor McNamara Stock Analyst Profile - RBC Capital Research Coverage - Stocknear

Conor McNamara

Stock Analyst at RBC Capital

(2.75)
# 3106
Out of 5,506 analysts
125
Total ratings
Success rate
Average return

14 Stocks

Name Action PT Current % Upside Ratings Updated
TECH Bio-Techne
Upgrades: Outperform
61 73
62.94 15.98% 11 Sep 3, 2025
MRVI Maravai LifeSciences
Maintains: Outperform
7 5
3.09 61.81% 7 Aug 12, 2025
NTRA Natera
Maintains: Outperform
251 255
167.35 52.38% 2 Aug 8, 2025
OABI OmniAb
Maintains: Outperform
4 3
1.63 84.05% 4 Aug 7, 2025
EXAS Exact Sciences
Maintains: Sector Perform
54 46
56.72 -18.9% 1 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
72 87
68.22 27.53% 12 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 17
14.29 18.96% 9 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
118 126
102.12 23.38% 16 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
387 409
305.8 33.75% 12 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
193 204
148.73 37.16% 12 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
651 637
543.55 17.19% 14 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
250 250
214.72 16.43% 10 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 61
29.98 103.47% 11 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 7
4.4 59.09% 4 Aug 7, 2024